当社グループは 3,000 以上の世界的なカンファレンスシリーズ 米国、ヨーロッパ、世界中で毎年イベントが開催されます。 1,000 のより科学的な学会からの支援を受けたアジア および 700 以上の オープン アクセスを発行ジャーナルには 50,000 人以上の著名人が掲載されており、科学者が編集委員として名高い

オープンアクセスジャーナルはより多くの読者と引用を獲得
700 ジャーナル 15,000,000 人の読者 各ジャーナルは 25,000 人以上の読者を獲得

抽象的な

Pathogenesis and Changing Management Philosophies in Diabetic Neuropathy

Jurses Heborn

Diabetic neuropathy, a common complication of diabetes mellitus, is characterized by damage to the peripheral nerves. The pathogenesis of this condition is complex, involving metabolic abnormalities, oxidative stress, inflammation, and microvascular changes. Over time, there has been an improved understanding of the underlying mechanisms, leading to evolving management philosophies for diabetic neuropathy. This abstract highlights the changing approaches in the management of diabetic neuropathy, focusing on targeting the underlying pathogenesis. The key management strategies include optimizing glycemic control, addressing multifactorial risk factors, implementing antioxidant and anti-inflammatory therapies, utilizing neurotrophic factors and growth modulators, and providing symptomatic relief. These changing management philosophies aim to not only alleviate symptoms but also slow the progression of neuropathy and improve patient outcomes. The comprehensive management of diabetic neuropathy involves a multidisciplinary approach, incorporating lifestyle modifications, pharmacotherapy, and rehabilitative interventions. Further research and advancements in the understanding of the pathogenesis of diabetic neuropathy are essential to develop more targeted and effective treatments for this debilitating condition.